140 related articles for article (PubMed ID: 3145888)
1. Quantitative bone scintigraphy: usefulness in the survey of patients treated for bone metastasis of prostatic cancer.
Grob JC; Lallot C; Methlin G; Bollack C
Eur Urol; 1988; 15(3-4):193-5. PubMed ID: 3145888
[TBL] [Abstract][Full Text] [Related]
2. Quantitative bone scintigraphy and 24-hour whole-body counting of 99mTc-methylene diphosphonate in patients with prostatic carcinoma.
Sundkvist GM; Ahlgren L; Lilja B; Mattsson S
Nuklearmedizin; 1992 Oct; 31(5):178-81. PubMed ID: 1465355
[TBL] [Abstract][Full Text] [Related]
3. Study of the Usefulness of Bone Scan Index Calculated From 99m-Technetium- Hydroxymethylene Diphosphonate (
Higashiyama S; Yoshida A; Kawabe J
Curr Med Imaging; 2021; 17(1):89-96. PubMed ID: 32484112
[TBL] [Abstract][Full Text] [Related]
4. Quantitative bone scintigraphy. A methodological evaluation in prostate cancer.
Rydh A; Ahlström KR; Larsson A; Johansson L; Damber JE; Tomiç R; Hietala SO
Acta Radiol; 2000 Mar; 41(2):183-8. PubMed ID: 10741795
[TBL] [Abstract][Full Text] [Related]
5. [Bone scintigraphy in bone metastases due to prostatic cancer].
Hidaka H; Ishino Y; Nakayama C; Nakata H; Okamura T
J UOEH; 1987 Dec; 9(4):369-77. PubMed ID: 3438611
[TBL] [Abstract][Full Text] [Related]
6. The usefulness of bone-marrow scintigraphy in the detection of bone metastasis from prostatic cancer.
Otsuka N; Fukunaga M; Sone T; Yoneda M; Saito N; Tanaka H; Tomomitsu T; Yanagimoto S; Muranaka A; Morita R
Eur J Nucl Med; 1985; 11(8):319-22. PubMed ID: 4076240
[TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8. Quantitative bone scan and bone metastases in prostatic cancer.
Grob JC; Thiel J; Méthlin G; Wolf P; Bollack C
Urol Int; 1985; 40(1):45-7. PubMed ID: 3156441
[TBL] [Abstract][Full Text] [Related]
9. [The usefulness of early whole body bone scintigraphy in the detection of bone metastasis from prostatic cancer].
Otsuka N; Fukunaga M; Furukawa Y; Tanaka H
Kaku Igaku; 1994 Jun; 31(6):541-50. PubMed ID: 7520953
[TBL] [Abstract][Full Text] [Related]
10. [Clinical usefulness of 123I-IMP scintigraphy in the diagnosis of bone metastases from hepatocellular carcinoma: comparison with 99mTc-MDP bone scintigraphy].
Suto Y; Tanigawa N; Iwamiya T; Kato T; Endo K; Shabana M; Ohta Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug; 53(8):953-9. PubMed ID: 8396760
[TBL] [Abstract][Full Text] [Related]
11. Preserved value of bone scintigraphy for the detection of skeletal metastases in prostate cancer patients with low prostate-specific antigen levels: effect of hormonal therapy and poor histologic differentiation.
Caglar M; Tuncel M
Clin Nucl Med; 2002 Jul; 27(7):532-3. PubMed ID: 12072787
[No Abstract] [Full Text] [Related]
12. [The early scintigraphic diagnosis of bone metastases in prostatic carcinoma].
Petrov T; Tsvetkov M; Mladenov D; Kumanov Kh
Khirurgiia (Sofiia); 1991; 44(5):28-9. PubMed ID: 1844461
[TBL] [Abstract][Full Text] [Related]
13. Predicting the Prognosis of Prostate Cancer Bone Metastasis Using the Bone Scan Index and Hot Spots Calculated Using VSBONEⓇ Bone Scan Index from Tc-99m-Hydroxymethylene Diphosphonate Bone Scintigraphy.
Higashiyama S; Yoshida A; Kawabe J
Urol Int; 2022; 106(9):963-969. PubMed ID: 35249033
[TBL] [Abstract][Full Text] [Related]
14. Additional information from quantitative 24-hour 99mTc-MDP bone scintigraphy in patients with prostatic carcinoma.
Sundkvist GM; Ahlgren L; Lilja B; Mattsson S
Acta Oncol; 1991; 30(5):635-9. PubMed ID: 1892682
[TBL] [Abstract][Full Text] [Related]
15. Prediction of tumor absorbed dose by Tc-99m-MDP scintigraphy prior to treatment with Sr-89.
Manetou A; Limourls GS
Anticancer Res; 1997; 17(3B):1845-7. PubMed ID: 9179243
[TBL] [Abstract][Full Text] [Related]
16. [The usefulness of bone marrow scintigraphy in the detection of bone metastasis from prostatic cancer].
Otsuka N; Fukunaga M; Morita R; Sone T; Yoneda M; Saito N; Tanaka H; Tomomitsu T; Yanagimoto S; Muranaka A
Kaku Igaku; 1985 Feb; 22(2):169-76. PubMed ID: 3159922
[No Abstract] [Full Text] [Related]
17. Distribution of skeletal metastases in prostatic and lung cancer. Mechanisms of skeletal metastases.
Morgan JW; Adcock KA; Donohue RE
Urology; 1990 Jul; 36(1):31-4. PubMed ID: 2368229
[TBL] [Abstract][Full Text] [Related]
18. [Local bone pain and osseous scintigraphic findings in patients with metastatic bone tumor].
Imaeda T; Iinuma G; Hirota K; Inoue A; Sone Y; Seki M; Suzuki M; Doi H
Kaku Igaku; 1988 Dec; 25(12):1319-27. PubMed ID: 3249457
[No Abstract] [Full Text] [Related]
19. Repeated quantitative bone scintigraphy in patients with prostatic carcinoma treated with orchiectomy.
Sundkvist GM; Ahlgren L; Lilja B; Mattsson S; Abrahamsson PA; Wadström LB
Eur J Nucl Med; 1988; 14(4):203-6. PubMed ID: 3169056
[TBL] [Abstract][Full Text] [Related]
20. [Patterns of bone metastases of carcinoma of the prostate: evaluation using 99mTC-MDP bone scintigraphy].
Matsuda H; Sakashita S; Arakawa M; Koyanagi T
Nihon Hinyokika Gakkai Zasshi; 1987 Oct; 78(10):1809-13. PubMed ID: 3444173
[No Abstract] [Full Text] [Related]
[Next] [New Search]